This link will take you to a page that’s not on LinkedIn

Because this is an external link, we’re unable to verify it for safety.

https://www.lefigaro.fr/economie/ose-immunotherapeutics-la-biotech-francaise-qui-veut-transformer-l-immunotherapie-20250616